Company Description
Not far from the center of the controversy over human embryonic stem cell (hESC) research is Geron. The company hopes to parlay its work into viable...
Key Geron Financials
| Company Type | Public - NASDAQ (GM): GERN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $7.6 |
| 2005 Employees | 90 |
More Geron Financials (11 pages)
Latest Geron Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Geron's competition across multiple industries
Top Geron Competitors
Sponsored Links
The Business Directory
Geron Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Alexander E. (Alex) Barkas | Network | E-mail |
| President, CEO, and Director; President, Oncology | Thomas B. Okarma | Network | E-mail |
| EVP, CFO, Treasurer, and Secretary | David L. Greenwood | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Geron News
- BioTime shares on big time roll [Contra Costa Times (Walnut Creek, CA)] (27 Aug 2008 04:00:00 EDT)
- SECURITIES AND EXCHANGE COMMISSION NEWS DIGEST [SEC News Digest] (26 Aug 2008 00:01:00 EDT)
- Feeder-free culture method for embryonic stem cells or primate primordial stem cells [U.S. Patents] (25 Aug 2008 12:24:00 EDT)
Sponsored Opportunity
